Related by context. Frequent words. (Click for all words.) 71 irrevocable perpetual 60 human antibody therapeutics 59 commercialize telaprevir 57 Argatroban 57 AeroLEF R 56 AZX# 55 Initiates Phase II 54 Scancell 54 Exclusive License 54 developing biomedical countermeasures 54 sublicensed 54 UltiMAb R 54 Nimotuzumab 54 BioWa 53 Rotarix R 53 R sorafenib tablets 53 Epitomics 53 Nippon Kayaku 53 sublicense 52 Commercialization Agreement 52 Microcyn Technology platform 52 Chrysalin 52 Marketing Authorisation 52 Covalon Technologies Ltd. 52 Exclusive License Agreement 52 Æterna Zentaris 52 therapeutic monoclonal antibodies 52 Vaccinex 51 Testim R 51 Patent Covering 51 Allovectin 7 R 51 AutoImmune 51 Orphan Medicinal Product 51 Poly ICR 51 Marketing Authorization 51 Orphan Drug status 51 Ampligen r 51 Loramyc R 51 novel antibody therapeutics 51 PER.C6 51 PER.C6 ® 50 ophthalmic indications 50 orphan medicinal product 50 DC Bead 50 apaziquone 50 Prestara 50 Acquires Exclusive 50 antibody phage display 50 Eligard R 50 Biovail Laboratories International 50 Clevudine 50 FDA Accepts 50 prodrugs 50 BioSilicon TM 50 optical biosensors 50 Aurexis 50 immunotherapeutics 50 AdnaGen 50 Fast Track Designation 50 Daily downloadable PDF 50 XERECEPT 49 topical anti infective 49 Pennsaid R 49 ATryn ® 49 Durect 49 Adagen 49 Onalta 49 FDA Orphan Drug 49 siRNA therapeutics 49 Each Broker Warrant 49 ASONEP 49 BioGlue R 49 Elan Pharma 49 Oncaspar 49 Captisol 49 nitric oxide donating 49 Morphotek 49 Pharmion Corporation 49 Teijin Pharma 49 Investigational Device Exemption 49 Veronate 49 Uracyst ® 49 ONTAK 49 Nanobodies 49 Announces Initiation 49 antisense drug 49 CFFT 49 Orphan Drug Status 49 Uracyst R 49 Announces FDA Clearance 49 Develop Novel 49 Ceragenix 49 Brentuximab vedotin 48 sublicenses 48 Completes Enrollment 48 SENSIO Technologies Inc. 48 Syntonix 48 Humanitarian Device Exemption 48 Epson disclaims 48 Exercises Option 48 NGEx